|
1
|
A JemalR SiegelE WardT MurrayJ XuMJ
ThunCancer statistics, 2007CA Cancer J
Clin574366200710.3322/canjclin.57.1.43
|
|
2
|
AC LockhartML RothenbergJD BerlinTreatment
for pancreatic cancer: current therapy and continued
progressGastroenterology12816421654200510.1053/j.gastro.2005.03.03915887156
|
|
3
|
CJ WraySA AhmadJB MatthewsAM LowySurgery
for pancreatic cancer: recent controversies and current
practiceGastroenterology12816261641200510.1053/j.gastro.2005.03.03515887155
|
|
4
|
B GudjonssonPancreatic cancer: survival
errors and evidenceEur J Gastroenterol
Hepatol2113791382200910.1097/MEG.0b013e328323aab719907226
|
|
5
|
S FuldaTumor resistance to apoptosisInt J
Cancer124511515200910.1002/ijc.2406419003982
|
|
6
|
D HanahanRA WeinbergThe hallmarks of
cancerCell1005770200010.1016/S0092-8674(00)81683-9
|
|
7
|
S VogelS OhmayerG BrunnerJ HeilmannNatural
and non-natural prenylated chalcones: synthesis, cytotoxicity and
anti-oxidative activityBioorg Med
Chem1642864293200810.1016/j.bmc.2008.02.07918343123
|
|
8
|
J TangN LiH DaiK WangChemical constituents
from seeds of Alpinia katsumadai, inhibition on NF-kappaB
activation and antitumor effectZhongguo Zhong Yao Za
Zhi35171017142010(In Chinese)
|
|
9
|
S WangL ZhouW HeZ HuSeparation and
determination of alpinetin and cardamonin by reverse micelle
electrokinetic capillary chromatographyJ Pharm Biomed
Anal4315571561200710.1016/j.jpba.2006.11.02117240102
|
|
10
|
W HeY LiJ TangF LuanJ JinZ HuComparison of
the characterization on binding of alpinetin and cardamonin to
lysozyme by spectroscopic methodsInt J Biol
Macromol39165173200610.1016/j.ijbiomac.2005.11.00316828496
|
|
11
|
SN MalekCW PhangH IbrahimAW NorhanomKS
SimPhytochemical and cytotoxic investigations of Alpinia
mutica
rhizomesMolecules16583589201110.3390/molecules1601058321240148
|
|
12
|
LL InMN AzmiH IbrahimK AwangNH
Nagoor1′S-1′-acetoxyeugenol acetate: a novel phenylpropanoid from
Alpinia conchigera enhances the apoptotic effects of
paclitaxel in MCF-7 cells through NF-κB inactivationAnticancer
Drugs224244342011
|
|
13
|
ZH HeW GeGG YueCB LauMF HePP
ButAnti-angiogenic effects of the fruit of Alpinia
oxyphyllaJ
Ethnopharmacol132443449201010.1016/j.jep.2010.08.02420723592
|
|
14
|
R HamacherRM SchmidD SaurG
SchneiderApoptotic pathways in pancreatic ductal adenocarcinomaMol
Cancer764200810.1186/1476-4598-7-6418652674
|
|
15
|
J CuiR SunY YuS GouG ZhaoC
WangAntiproliferative effect of resveratrol in pancreatic cancer
cellsPhytother Res2416371644201010.1002/ptr.315721031621
|
|
16
|
K ShojiM TsubakiY YamazoeT SatouT ItohY
KideraY TanimoriM YanaeH MatsudaA TagaMangiferin induces apoptosis
by suppressing Bcl-xL and XIAP expressions and nuclear entry of
NF-κB in HL-60 cellsArch Pharm Res34469475201121547680
|
|
17
|
C KöhlerS OrreniusB ZhivotovskyEvaluation
of caspase activity in apoptotic cellsJ Immunol
Methods265971102002
|
|
18
|
B TangY ZhangR LiangP YuanJ DuH WangL
WangActivation of the δ-opioid receptor inhibits serum
deprivation-induced apoptosis of human liver cells via the
activation of PKC and the mitochondrial pathwayInt J Mol
Med28107710852011
|
|
19
|
A ArltSS MüerkösterH SchäferTargeting
apoptosis pathways in pancreatic cancerCancer LettNov 132010(Epub
ahead of print)
|
|
20
|
A BurlacuRegulation of apoptosis by bcl-2
family proteinsJ Cell Mol
Med7249257200310.1111/j.1582-4934.2003.tb00225.x14594549
|
|
21
|
S CoryJM AdamsThe Bcl2 family: regulators
of the cellular life-or-death switchNat Rev
Cancer2647656200210.1038/nrc88312209154
|
|
22
|
T KuwanaMR MackeyG PerkinsMH EllismanM
LatterichR SchneiterDR GreenDD NewmeyerBid, Bax, and lipids
cooperate to form supramolecular openings in the outer
mitochondrial
membraneCell111331342200210.1016/S0092-8674(02)01036-X12419244
|
|
23
|
EH ChengB LevineLH BoiseCB ThompsonJM
HardwickBax-independent inhibition of apoptosis by
Bcl-xLNature379554556199610.1038/379554a08596636
|
|
24
|
XM YinZN OltvaiSJ KorsmeyerBH1 and BH2
domains of Bcl-2 are required for inhibition of apoptosis and
heterodimerization with
BaxNature369321323199410.1038/369321a08183370
|
|
25
|
HH WongNR LemoinePancreatic cancer:
molecular pathogenesis and new therapeutic targetsNat Rev
Gastroenterol
Hepatol6412422200910.1038/nrgastro.2009.8919506583
|
|
26
|
S FuldaApoptosis pathways and their
therapeutic exploitation in pancreatic cancerJ Cell Mol
Med1312211227200910.1111/j.1582-4934.2009.00748.x19382915
|
|
27
|
JM AdamsS CoryThe Bcl-2 protein family:
arbiters of cell
survivalScience28113221326199810.1126/science.281.5381.13229735050
|
|
28
|
JC ReedDouble identity for proteins of the
Bcl-2 familyNature387773776199710.1038/428679194558
|
|
29
|
SJ RiedlY ShiMolecular mechanisms of
caspase regulation during apoptosisNat Rev Mol Cell
Biol5897907200410.1038/nrm149615520809
|
|
30
|
M ChenJ WangInitiator caspases in
apoptosis signaling
pathwaysApoptosis7313319200210.1023/A:1016167228059
|
|
31
|
SY ChienYC WuJG ChungJS YangHF LuMF TsouWG
WoodSJ KuoDR ChenQuercetin-induced apoptosis acts through
mitochondrial- and caspase-3-dependent pathways in human breast
cancer MDA-MB-231 cellsHum Exp
Toxicol28493503200910.1177/096032710910700219755441
|
